Biotech - Press Releases

Date	Title	Company
31-Oct-2019	First NHS patient receives Chiesi’s advanced-therapy-medicinal product, Holoclar▼ for moderate-to-severe limbal stem cell deficiency (LSCD) caused by chemical or thermal eye burns	Chiesi UK
31-Oct-2019	Investigational Ebola Vaccine from Janssen and Bavarian Nordic to Support Outbreak Response in Democratic Republic of the Congo	Bavarian Nordic A/S
31-Oct-2019	More than 600 top-notch technologies make a bang at Agri-Tech Expo & Forum 2019	Informa Markets (UBM Asia Ltd., Taiwan Branch)
31-Oct-2019	Johnson & Johnson Vision Launches TECNIS Eyhance™ Monofocal Intraocular Lens in India	Johnson & Johnson Vision
31-Oct-2019	Natural Extracts Innovated, Transformed and Diversely Laid Out to Embrace the Blue Ocean Market of Big Health	NEX China 2020
31-Oct-2019	TSRL Announces the Appointments of Martha Farmer and Stephen Munk to Board of Directors, and Gregory Amidon as Chairman of the Board	TSRL, Inc.
30-Oct-2019	Protagonist Therapeutics Initiates Phase 2 Study of Novel Hepcidin Mimetic PTG-300 in the Treatment of Patients with Polycythemia Vera	Protagonist Therapeutics, Inc.
30-Oct-2019	AIVITA Biomedical Announces Publication Detailing Immune Mechanisms Leading to Complete Remission of Measurable Metastatic Melanoma in Patient Treated with AIVITA Immunotherapy	AIVITA Biomedical, Inc.
30-Oct-2019	ProteoGenix Launches New Human and Rabbit Antibody Libraries to Speed Up the Discovery of Better Therapeutic and Analytical Antibodies	ProteoGenix
30-Oct-2019	Navigating the Globalisation of Clinical Trials	Medidata
30-Oct-2019	MultiTEP Platform-Based Epitope Vaccine Targeting the Phosphatase Activating Domain (PAD) of Tau Shows Clear Therapeutic Efficacy in PS19 Mice	Capo Therapeutics, Inc
30-Oct-2019	Sanifit announces that the Phase 2b CaLIPSO trial of SNF472 met its primary endpoint in slowing the progression of cardiovascular calcification in patients on hemodialysis Top line data to be presented at 2019 Scientific Sessions of American Heart Association	Sanifit
30-Oct-2019	New ImpactAir ISO-90 microbial air sampler	CHERWELL LABORATORIES
30-Oct-2019	Dupixent® (dupilumab) now approved in European Union for severe chronic rhinosinusitis with nasal polyposis	Regeneron
30-Oct-2019	Anatomic Pathology Market Worth $44.4 Billion by 2024 - Exclusive Report by MarketsandMarkets™	MarketsandMarkets
30-Oct-2019	ESSA Pharma Grants Stock Options	ESSA Pharma Inc
30-Oct-2019	United Therapeutics Corporation Reports Third Quarter 2019 Financial Results	United Therapeutics Corporation
30-Oct-2019	EC Approves Astellas' XOSPATA(TM) for Patients with Relapsed or Refractory Acute Myeloid Leukemia with Mutations Detected using Invivoscribe's LeukoStrat(R) CDx FLT3 Mutation Assay	Invivoscribe, Inc.
30-Oct-2019	LEO PHARMA ENTERS INTO OPTION AGREEMENT WITH UBIQUIGENT FOR ACCESS TO NOVEL COMPOUNDS	Ubiquigent
30-Oct-2019	Danaher Announces Pricing Of Senior Notes Offering	Danaher Corporation